Senators Consider Fees On PBMs To Help Close Donut Hole
This article was originally published in The Pink Sheet Daily
Executive Summary
Pharmacy benefit management companies are objecting to an idea that an annual fee on PBMs could be levied to go towards eliminating the Medicare Part D gap in drug coverage.
You may also be interested in...
As Health Reform Takes Final Shape, Pharma Provisions Still In Play
Even as news that a breakthrough on one of the major issues separating the House and Senate health care reform bills - taxing high-cost health care plans -emerged near the end of the week of Jan. 11, issues of keen interest for biopharma stakeholders remained unsettled
As Health Reform Takes Final Shape, Pharma Provisions Still In Play
Even as news that a breakthrough on one of the major issues separating the House and Senate health care reform bills - taxing high-cost health care plans -emerged near the end of the week of Jan. 11, issues of keen interest for biopharma stakeholders remained unsettled
PhRMA Deal Intact As Senate Health Reform Bill Enters Home Stretch
The $80 billion deal struck last spring between the White House, Senate Finance Committee Chairman Max Baucus, D-Mont., and the Pharmaceutical Research and Manufacturers of America remained in force as the full Senate moved toward the end of its third week of debating the bill